Saccharomyces Cerevisiae Glucan IgA

ASCA IgA is useful when Crohn's is already a real possibility. If you've had months of diarrhea, cramping, weight loss, or anemia, a positive result adds weight to Crohn's, especially small-bowel Crohn's. It does not diagnose Crohn's by itself.

It works best as a rule-in clue. It is weak as a rule-out test. That is the central point: a positive result can matter, but a negative result should not stop a workup when the symptoms still fit.

What This Test Measures

The test measures ASCA IgA in serum from a blood draw. The full name is anti-Saccharomyces cerevisiae antibody, immunoglobulin A class. Saccharomyces cerevisiae is the yeast used in baking and brewing. ASCA is aimed mainly at mannan. Mannan is a sugar-rich part of the yeast cell wall.

IgA is an antibody class tied to lining surfaces such as the gut. Serum ASCA IgA seems to reflect gut immune activity more than oral immune activity. A study that measured both blood and saliva found that serum IgA to Saccharomyces was raised in people with gut Crohn's, while salivary IgA tracked oral disease.

How Mature This Marker Is

ASCA is a commercial lab marker with many outcome and diagnostic studies behind it, but it is still an adjunctive test. Gastroenterology guidelines put diagnosis on symptoms, stool tests, infection testing, endoscopy with biopsy, and bowel imaging. ASCA can help when the diagnosis is unclear, especially Crohn's versus ulcerative colitis, but it is not recommended as routine screening.

The Crohn's Disease Signal

ASCA IgA is more specific than sensitive. In large and pooled studies of ASCA testing, specificity is often near 90% or higher, while sensitivity is usually around half and is lower in some groups. So a positive result has weight. A negative result does not clear you.

Most published diagnostic numbers come from ASCA panels that measure IgA, IgG, or both. IgA alone is usually a little less sensitive than combined testing. That matters if your report shows only IgA.

Higher levels make Crohn's more likely, but the result is still assay-dependent. Different commercial kits use different cutoffs and antigens, so a high result from one lab cannot be cleanly compared with another.

Crohn's Versus Ulcerative Colitis

The best-known pattern uses ASCA with pANCA. pANCA is another antibody test used in IBD workups. ASCA positive with pANCA negative points toward Crohn's in many cohorts; pANCA positive with ASCA negative leans toward ulcerative colitis. The pattern helps most when colonoscopy or imaging has left the diagnosis unsettled.

Before Diagnosis

The antibody can appear before symptoms or before a formal diagnosis. In the 2005 military serum-bank study, 10 of 32 future Crohn's cases were ASCA-positive before diagnosis. The average lead time among positive cases was 38 months. A later military cohort used ASCA IgA or IgG plus many proteins and predicted Crohn's better within one year than within five. That was a research model, not a clinical rule you can apply to one ASCA IgA result.

Family history changes the usefulness. Healthy first-degree relatives of Crohn's patients can carry ASCA. Several family studies put that number around one in five to one in four. A positive result in that setting says your immune pattern resembles part of the Crohn's pattern; it does not mean Crohn's is inevitable.

Other Conditions That Can Raise It

Crohn's is the main use case, but it is not the only setting. ASCA can rise in active celiac disease, autoimmune liver disease, Behçet's disease with gut involvement, ankylosing spondylitis and related spine-and-joint disease, rheumatoid arthritis, and some antiphospholipid-antibody states. One small Parkinson's study also found higher serum ASCA IgA and IgG in newly diagnosed Parkinson's disease, but that is early case-control evidence.

The shared theme is an immune system that has started reacting to yeast-related sugars. That can happen in more than one disease. Your symptoms, stool inflammation, celiac testing, imaging, and biopsy decide what the result means.

Disease Behavior in Crohn's

In Crohn's, ASCA positivity tends to travel with small-bowel involvement and a more complicated course: scarring, tunnel-forming disease, and surgery show up more often in ASCA-positive groups. Higher titers have also been tied to more complicated disease. This is prognosis, not a live flare meter.

In adults, ASCA is usually fairly stable. It can stay positive after inflamed bowel is removed and does not reliably predict recurrence after surgery. In children, some studies find closer links with disease activity and treatment response, so age matters.

When Results Can Be Misleading

• Different assays: ASCA tests are not standardized. One comparison found sensitivity ranged from 41% to 76% by kit, so compare only the same lab and method.
• IgA deficiency: this test measures IgA-class ASCA. Low total IgA can make IgA-based tests falsely low.
• Children and disease activity: pediatric ASCA can be lower during quiet disease and higher during severe active disease, so timing can matter more in children than adults.
• Recent steroids: prednisolone lowered ASCA IgA and IgG within weeks in one Crohn's study. That can make the number fall without proving the disease is gone.
• Cross-reacting antibodies: certain antiphospholipid antibodies can cross-react with yeast targets. In one study, ASCA was more common in people with those antibodies than in controls.
• Saliva is different: salivary ASCA IgA reflects oral immune activity more than gut disease. This article is about serum ASCA IgA from blood.

How To Use One Result

A positive result with gut symptoms should move you toward a proper IBD workup, not a self-diagnosis. The confirming tests are endoscopy with biopsy and bowel imaging. Stool calprotectin helps show whether there is active gut inflammation, and pANCA can add context when the question is Crohn's versus ulcerative colitis. A gastroenterologist is needed for endoscopy, biopsy, and treatment decisions.

A negative result with ongoing symptoms should not stop the workup. A positive result without gut symptoms should be read more cautiously. Start by checking for celiac disease with tTG IgA and total IgA, then look for liver, joint, antiphospholipid-antibody, or neurological clues only if your history points there. In places where intestinal tuberculosis or intestinal Behçet's disease are plausible, ASCA does not separate them from Crohn's well; a different antibody called anti-GP2 has performed better in that specific comparison.